Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.00 USD
Change Today -0.06 / -2.91%
Volume 89.7K
VRML On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-François Formela M.D., MBA

AgeTotal Calculated CompensationThis person is connected to 131 board members in 19 different organizations across 26 different industries.

See Board Relationships
58--

Background*

Dr. Jean-François Formela, M.D., MBA is a Partner of Atlas Venture L.P.; Atlas Venture Fund VI, L.P.; and Atlas Venture Fund VII, L.P. Mr. Formela is a part of the life sciences group and focuses on new advances in biology and drug discovery technologies as well as novel therapeutics. He serves as an Executive at Vermillion, Inc. He joined Atlas Venture in 1993 and served as a Principal from 1993 to 1995. Prior to joining Atlas Venture, Dr. Formela served as a senior ...

Read Full Background

Corporate Headquarters*

Building III
Austin, Texas 78738

United States

Phone: 512-519-0400
Fax: 512-439-6980

Board Members Memberships*

Director
Chairman
Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
Director
1997-Present
Director
2003-Present
Director
2010-Present
Director, Chairperson of Compensation Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director

Education*

MBA
Columbia Business School
MD
Medical University of Paris

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRML:US $2.00 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gon-Emon Kurihara President and Representative Director
Jeol Ltd.
--
Russell Cummings Chief Executive Officer, Executive Director and Member of Investment Committee
Imperial Innovations Group plc
403.0K GBP
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
C$216.7K
Rene A. Schena Chairman and Chief Executive Officer
Arrayit Corporation
$78.8K
Jan Groen Ph.D.Chief Executive Officer, President and Executive Director
MDxHealth SA
€491.1K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERMILLION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.